Home > Products > CD64 & HIV-1 gp41
> Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG)
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) (CAT#: SCIGG-127)
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD64 and anti-HIV-1 gp41 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of HIV-1 infection, AIDS therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) (SCIGG-127). Click the button below to contact us or submit your feedback about this product.